Medicines and Healthcare products Regulatory Agency
| 1: Authorisation Number | UK MIA 18756 |
|---|---|
| 2: Name of authorisation holder | CHESTER MEDICAL SOLUTIONS |
| 3: Address(es) of manufacturing site(s) |
CHESTER MEDICAL SOLUTIONS, UNITS 3,4,7 & 8, APEX COURT, BASSENDALE ROAD, WIRRAL, CH62 3RE, UNITED KINGDOM |
| 4: Legally registered address of authorisation holder | CHESTER MEDICAL SOLUTIONS, 3-4 APEX COURT, BASSENDALE ROAD, WIRRAL, CH62 3RE, UNITED KINGDOM |
| 5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 |
| 6: Legal Basis of authorisation | |
| 7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential |
| 8: Authorisation Date | 10/10/2023 |
| 9: Annexes attached | Annex 1 and/or Annex 2 |
SCOPE OF AUTHORISATION
Annex 1
Name and address of the site:
CHESTER MEDICAL SOLUTIONS, UNITS 3,4,7 & 8, APEX COURT, BASSENDALE ROAD, WIRRAL, CH62 3RE, UNITED KINGDOM
Human Medicinal Products
| Authorised Operations |
| MANUFACTURING OPERATIONS (according to part 1) |
| Part 1 - MANUFACTURING OPERATIONS |
| [ 1.1 ] Sterile Products |
| [ 1.1.3 ] Batch certification |
| [ 1.5 ] Packaging |
| [ 1.5.1 ] Primary packaging |
| [ 1.5.1.1 ] Capsules, hard shell |
| [ 1.5.1.2 ] Capsules, soft shell |
| [ 1.5.1.3 ] Chewing gums |
| [ 1.5.1.4 ] Impregnated matrices |
| [ 1.5.1.8 ] Other solid dosage forms |
| [ 1.5.1.12 ] Suppositories |
| [ 1.5.1.13 ] Tablets |
| [ 1.5.1.14 ] Transdermal patches |
| [ 1.5.2 ] Secondary packaging |
| [ 1.6 ] Quality control testing |
| [ 1.6.3 ] Chemical/Physical |